Loading...
Choose your dose tier
Which tirzepatide dose is right for you?
Tier eligibility depends on BMI and health history. Final tier is confirmed by your clinician based on your full medical intake.
MicrodoseLightest
Microdose
Up to 2.5 mg / week. Anti-inflammatory, longevity, gentle metabolic optimization.
Low DoseTherapeutic
Low Dose
Up to 5 mg / week. Most patients report steady weight loss without titrating to full dose.
NormalFull Dose
Normal
Titrating up to 12.5 mg / week. Clinical weight-loss, with higher dose flexibility and precision than brand-name versions.
Final tier is confirmed by your clinician based on your full medical intake.
A note on our packaging
Notice our bottles are not labeled.
That's intentional. We do not white-label our medications. Your dispensing pharmacy applies the official prescription label at the moment your order is filled. The label includes their name, your name, and full lot details. You will always know exactly which licensed 503A pharmacy compounded your medication.
Tirzepatide Microdose
Lightest Dose • Longevity & Metabolic Optimization
Up to 2.5 mg / week • Subcutaneous • RefrigeratedA sub-therapeutic dose used primarily for anti-inflammatory, longevity, and metabolic health goals, not aggressive weight loss. Pairs well with fitness, peptide stacks, and longevity protocols.
What patients report
- Calmer "food noise" without strong appetite suppression
- Improved insulin sensitivity and lower fasting glucose
- Steadier energy through the day
- Reduced inflammation markers
Who qualifies?BMI 19 to 21.9 by default, or any BMI if your goal is anti-inflammatory support, longevity, or metabolic optimization rather than aggressive weight loss. Weight loss is not required. Higher-BMI patients are welcome to microdose for the underlying metabolic benefits.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. Activation of both gut hormone pathways:
- Slows how fast the stomach empties
- Improves insulin sensitivity
- Lowers fasting and post-meal glucose
- Reduces appetite signaling
Each monthly shipment includes:
- One pharmaceutical-grade tirzepatide vial (microdose strength), pre-mixed and ready to use, no mixing required
- Injection needles
- Alcohol prep wipes
- Self-administration instructions
- Unlimited messaging with your care team
The vial in our product photos has a blank label. That is intentional. We do not white-label our medications.
Every tirzepatide vial is dispensed by a state-licensed 503A compounding pharmacy. The pharmacy applies the official prescription label at the moment your order is filled. The label includes their name, your name, the lot number, and full dispensing details. That label is the legal record of where your medication came from and who is accountable for it.
Many telehealth brands obscure this by relabeling vials with their own branding before shipping. We do not. You will always be able to see exactly which licensed pharmacy compounded your medication.
Every tirzepatide vial is dispensed by a state-licensed 503A compounding pharmacy. The pharmacy applies the official prescription label at the moment your order is filled. The label includes their name, your name, the lot number, and full dispensing details. That label is the legal record of where your medication came from and who is accountable for it.
Many telehealth brands obscure this by relabeling vials with their own branding before shipping. We do not. You will always be able to see exactly which licensed pharmacy compounded your medication.
The vial arrives fully pre-mixed and ready to inject, no mixing or preparation required.
Microdose protocol: Up to 2.5 mg subcutaneously, once weekly. Highly flexible titration based on your tolerance.
At the standard cadence, one month's vial supply lasts approximately one month.
Microdose protocol: Up to 2.5 mg subcutaneously, once weekly. Highly flexible titration based on your tolerance.
At the standard cadence, one month's vial supply lasts approximately one month.
Microdose tirzepatide pairs well with Tesamorelin (visceral fat), Sermorelin (recovery and sleep), and Lipo-C (energy). Each targets a different gap that GLP-1 alone leaves behind.
For weight loss specifically, the Low Dose or Normal tiers are more appropriate.
For weight loss specifically, the Low Dose or Normal tiers are more appropriate.
Currently shipping to: TX, CA, FL, NY. Additional states added regularly.
$140/mo
Monthly subscription • cancel anytime
Tirzepatide Microdose, Monthly
$140/mo
Free temperature-controlled shipping. Medication ships only after your clinician approves your protocol at your appointment.
- US Licensed Doctors and 503A Pharmacies
- Free Cold-Chain Shipping
- FSA & HSA Eligible
A note on our packaging
Notice our bottles are not labeled.
That's intentional. We do not white-label our medications. Your dispensing pharmacy applies the official prescription label at the moment your order is filled. The label includes their name, your name, and full lot details. You will always know exactly which licensed 503A pharmacy compounded your medication.
Tirzepatide Low Dose
Therapeutic • Steady Weight Loss
Up to 5 mg / week • Subcutaneous • RefrigeratedOur most popular starting tier. Delivers meaningful, sustainable weight loss with milder side effects than full Normal-range dosing. Many patients stay at Low Dose long-term rather than titrating up.
What patients report
- Steady weight loss within 8 to 12 weeks
- Reduced cravings and "food noise"
- Improved metabolic markers (A1c, fasting glucose, lipids)
- Meaningful changes in food relationship
- Retains the anti-inflammatory benefits of tirzepatide
Who qualifies?BMI 22 to 29.9 by default, or any BMI if you prefer a gentler, more sustainable approach for steady weight loss with anti-inflammatory and metabolic support. Higher-BMI patients are welcome to stay at Low Dose long-term rather than titrating to Normal.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. At Low Dose levels:
- How fast the stomach empties slows down enough to meaningfully reduce hunger
- Insulin sensitivity improves with measurable A1c reduction
- Appetite-suppression is present but milder than Normal-tier dosing
Each monthly shipment includes:
- One pharmaceutical-grade tirzepatide vial (Low Dose strength), pre-mixed and ready to use
- Injection needles
- Alcohol prep wipes
- Self-administration instructions
- Unlimited messaging with your care team
The vial in our product photos has a blank label. That is intentional. We do not white-label our medications.
Every tirzepatide vial is dispensed by a state-licensed 503A compounding pharmacy. The pharmacy applies the official prescription label at the moment your order is filled. The label includes their name, your name, the lot number, and full dispensing details.
You will always be able to see exactly which licensed pharmacy compounded your medication.
Every tirzepatide vial is dispensed by a state-licensed 503A compounding pharmacy. The pharmacy applies the official prescription label at the moment your order is filled. The label includes their name, your name, the lot number, and full dispensing details.
You will always be able to see exactly which licensed pharmacy compounded your medication.
The vial arrives fully pre-mixed and ready to inject.
Low Dose protocol: Up to 5 mg subcutaneously, once weekly. Highly flexible titration based on your tolerance.
Low Dose protocol: Up to 5 mg subcutaneously, once weekly. Highly flexible titration based on your tolerance.
Pairs well with Tesamorelin (visceral fat), Sermorelin (preserves muscle), and Lipo-C (energy during weight loss).
Currently shipping to: TX, CA, FL, NY. Additional states added regularly.
$170/mo
Monthly subscription • cancel anytime
Tirzepatide Low Dose, Monthly
$170/mo
Free temperature-controlled shipping. Medication ships only after your clinician approves your protocol at your appointment.
- US Licensed Doctors and 503A Pharmacies
- Free Cold-Chain Shipping
- FSA & HSA Eligible
A note on our packaging
Notice our bottles are not labeled.
That's intentional. We do not white-label our medications. Your dispensing pharmacy applies the official prescription label at the moment your order is filled. The label includes their name, your name, and full lot details. You will always know exactly which licensed 503A pharmacy compounded your medication.
Tirzepatide Normal
Full Dose • Medical Weight Management
Titrating up to 12.5 mg / week • Subcutaneous • RefrigeratedThe full clinical weight-loss dose, associated with the largest weight-loss results in trial data. Intended for patients with elevated BMI or related health conditions.
What patients report
- The largest weight reduction of any tier
- Marked appetite suppression and reduced "food noise"
- Significant improvements in A1c, blood pressure, and cholesterol panel
- Stacking with Tesamorelin or Sermorelin can amplify visceral fat reduction and help prevent muscle loss
At full dose, clinical trials reported up to 22.5% body-weight reduction over 72 weeks. Patients also see meaningful improvements in A1c, blood pressure, sleep apnea, and lipid markers.
Who qualifies?BMI 30+, OR BMI 27+ with any one condition like high blood pressure, type 2 diabetes, prediabetes, high cholesterol, sleep apnea, or heart disease.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. At Normal-tier dosing:
- Appetite suppression reaches full clinical effect
- Glucose regulation and insulin sensitivity are maximally improved
- Metabolic benefits (cholesterol panel, blood pressure, visceral fat) are most pronounced
Each monthly shipment includes:
- One pharmaceutical-grade tirzepatide vial (Normal-tier strength, dose adjusted to your titration step), pre-mixed
- Injection needles
- Alcohol prep wipes
- Self-administration instructions
- Unlimited messaging with your care team
The vial in our product photos has a blank label. That is intentional. We do not white-label our medications.
Every vial is dispensed by a state-licensed 503A compounding pharmacy. The pharmacy applies the official prescription label at the moment your order is filled. The label includes their name, your name, the lot number, and full dispensing details.
You will always be able to see exactly which licensed pharmacy compounded your medication.
Every vial is dispensed by a state-licensed 503A compounding pharmacy. The pharmacy applies the official prescription label at the moment your order is filled. The label includes their name, your name, the lot number, and full dispensing details.
You will always be able to see exactly which licensed pharmacy compounded your medication.
The vial arrives fully pre-mixed and ready to inject.
Normal protocol: Titrating up to 12.5 mg subcutaneously, once weekly. Highly flexible titration based on your tolerance.
Normal protocol: Titrating up to 12.5 mg subcutaneously, once weekly. Highly flexible titration based on your tolerance.
Pairs well with Tesamorelin (visceral fat), Sermorelin (preserves muscle through fast weight loss), and Lipo-C (energy and fatigue support).
Many Normal-tier patients also benefit from electrolyte support to manage transition-period side effects.
Many Normal-tier patients also benefit from electrolyte support to manage transition-period side effects.
Currently shipping to: TX, CA, FL, NY. Additional states added regularly.
$225/mo
Monthly subscription • cancel anytime
Tirzepatide Normal, Monthly
$225/mo
Free temperature-controlled shipping. Medication ships only after your clinician approves your protocol at your appointment.
- US Licensed Doctors and 503A Pharmacies
- Free Cold-Chain Shipping
- FSA & HSA Eligible
How it Works
1. Purchase and Medical History
Complete a brief health history at checkout. No charge unless approved.
2. Clinical Review
A licensed physician reviews your intake and, if appropriate, prescribes your protocol. Medications ship from a licensed 503A pharmacy.
3. At-Home Therapy
Simple self-administration, free cold-chain shipping, and ongoing support from your care team.
Is tirzepatide right for you?
A good fit
- Adult with a BMI of 19 or higher
- Open to weekly injection
- Wants clinician oversight
- Comfortable with monthly check-ins
Medical requirements
- Not pregnant or breastfeeding
- No history of pancreatitis
- No history of medullary thyroid carcinoma or MEN-2
Quality, safety, and transparency in every shipment
MicrodoseLow DoseNormalCraft Peptides only works with accredited, FDA-registered 503A pharmacies. Each batch is tested before shipment, and we carefully select pharmacy partners that go above and beyond the required standards.
Performed multiple times per week. Confirms the medication is within plus or minus 10% of the appropriate concentration of the active ingredient (required by law). Results are typically within just 2%.
Ensures the medication is free from contaminants including bacteria or other pathogens. Every batch is tested and must meet USP 797.1 requirements.
Assesses the acid/base balance to ensure minimal irritation upon injection.
Along with sterility testing, ensures the medication is free of harmful toxins. Every batch is tested for bacterial endotoxins, which may not exceed the threshold limits defined in USP 85.
Three tiers, one molecule, one trusted protocol.
Tirzepatide pricing scales with dose, not with marketing tiers. Your clinician confirms your tier based on BMI and health history.
Get StartedTirzepatide Three Dose Tiers
| Microdose | Low Dose | Normal | |
|---|---|---|---|
| Dose / week | Up to 2.5 mg | Up to 5 mg | Up to 12.5 mg |
| Tier intent | Longevity | Therapeutic | Full Dose |
| BMI range | 19 to 21.9 | 22 to 29.9 | 30+ or 27+ w/ condition |
| Price | $140/mo | $170/mo | $225/mo |
All tiers are monthly subscriptions, cancel anytime. Final tier confirmed by your clinician based on full medical intake.
Not sure which tier?
Take our GLP match.
Find My TierFrequently Asked Questions
What you're getting: Compounded tirzepatide, made by a state-licensed 503A pharmacy. The compounded medication is not FDA-approved; the active ingredient is.
When FDA-approved versions are appropriate: Zepbound (chronic weight management) is FDA-approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition (high blood pressure, type 2 diabetes, high cholesterol, sleep apnea, or cardiovascular disease). Mounjaro is approved for type 2 diabetes.
Why patients choose compounded: Compounded medications are appropriate when an FDA-approved version isn't a fit, for example, sub-therapeutic dosing for longevity or anti-inflammatory use (not commercially available), patients outside the FDA-approved BMI range (BMI 19 to 26 without qualifying related health conditions), intolerance to a brand formulation, or access barriers. Your clinician confirms clinical appropriateness during your medical review before any prescription is issued.
Microdose is not designed for weight loss as the primary outcome. Most patients on Microdose either maintain weight or see modest reduction over time. If weight loss is your main goal, your clinician will likely recommend Low Dose or Normal tier instead.
Yes. Patients with a higher BMI can choose Microdose if their primary goal is anti-inflammatory support, longevity, or metabolic optimization, not aggressive weight loss. Microdose still delivers most of tirzepatide's metabolic and anti-inflammatory benefits at a lower dose, with a gentler side effects.
If you are aiming for meaningful weight loss, your clinician will likely recommend Low Dose or Normal tier instead. Microdose is a decision your clinician makes based on your goals, not your BMI alone. Your clinician confirms the fit during your medical review.
Reduced appetite and food noise is often noticeable within the first 1 to 2 weeks. Measurable weight loss typically begins by week 4 to 6 at therapeutic dose, with the full arc continuing through 6 to 12 months.
Yes. Tier transitions are a clinical decision made with your provider during follow-up. Most patients who start on Microdose for longevity stay there. Patients on Low Dose may step up to Normal if they want continued weight loss after stabilization. Patients on Normal can step down to Low Dose for maintenance once they reach goal weight.
We also offer compounded semaglutide across the same three tiers. Tirzepatide produces somewhat more weight loss at full dose in head-to-head data. GI tolerance varies significantly by individual: some patients tolerate one better than the other. Your clinician can help you choose based on tolerance, goals, and history.
Currently shipping to: TX, CA, FL, NY. Additional states added regularly.
Safety Information
Tirzepatide is generally well-tolerated. Side effects are usually dose-dependent, which is why titration starts low and steps up gradually. Most side effects, when present, resolve as the body adjusts.
Most side effects, if present, are mild to moderate and improve as the body adjusts to dose changes. If side effects are uncomfortable, your clinician can pause titration or step down.
Possible side effects of tirzepatide include:
Possible side effects of tirzepatide include:
- Nausea (most common, especially during titration)
- Diarrhea or constipation
- Reduced appetite (intended effect at higher doses)
- Fatigue, especially early in titration
- Injection site reaction
- Acid reflux or "sulfur burps"
- Headache
Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors, based on rodent studies. The relevance to humans is unknown. Do not use if you or your family has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN-2).
Tirzepatide may increase the risk of pancreatitis. Stop the medication and contact your clinician if you experience severe abdominal pain that does not resolve.
Tirzepatide may increase the risk of pancreatitis. Stop the medication and contact your clinician if you experience severe abdominal pain that does not resolve.
Do not use tirzepatide if you:
Use with caution if you have:
- Are pregnant, planning pregnancy in the next 2 months, or breastfeeding
- Have a personal or family history of medullary thyroid carcinoma or MEN-2
- Have a history of pancreatitis
- Have severe gastrointestinal disease (gastroparesis, severe IBD)
- Have type 1 diabetes
Use with caution if you have:
- History of gallbladder disease
- Diabetic retinopathy
- Eating disorder history
- Severe kidney impairment
The active ingredient (tirzepatide) is FDA approved as the brand-name products Mounjaro and Zepbound. The compounded form we dispense is prepared by a state-licensed 503A pharmacy and is not itself FDA approved.
Compounded medications are customized pharmaceutical products offered as an alternative to FDA-approved medications. They may contain FDA-approved ingredients but are not themselves FDA reviewed for safety or effectiveness.
We work only with the best 503A pharmacies and require batch-level potency, sterility, pH, and purity testing on every shipment.
Compounded medications are customized pharmaceutical products offered as an alternative to FDA-approved medications. They may contain FDA-approved ingredients but are not themselves FDA reviewed for safety or effectiveness.
We work only with the best 503A pharmacies and require batch-level potency, sterility, pH, and purity testing on every shipment.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038. (SURMOUNT-1)
- Frias JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385(6):503-515. doi:10.1056/NEJMoa2107519. (SURPASS-2)
- Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626.
- Wadden TA, Chao AM, Machineni S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nat Med. 2023;29(11):2909-2918.
- Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48.
- Permana H, Yanto TA, Hariyanto TI. Comparing efficacy and safety of tirzepatide and semaglutide in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab Syndr. 2024;18(1):102945.
Interested in tirzepatide?
Not sure which tier fits? Take our 2-minute GLP match to find your tier.